GlassScriptPhysician profile
Theodore T Chang
NPI 1477503936
$5,241.57
in general payments reported to CMS, 2019-2025
44 companies · $1,091 in 2025
The $1,091 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $498 · 2021: $532 · 2022: $826 · 2023: $1,067 · 2024: $905 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,062.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $381.32 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $369.79 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Abbvie INC. | $340.55 | 2019-2024 | Lupron Depot, Botox |
| Sumitomo Pharma America, INC. | $340.31 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $327.00 | 2022-2024 | Jelmyto |
| Boston Scientific Corporation | $321.50 | 2020-2025 | Ams 700, Lumenis Pulse 120h, Rezum Generator |
| Coloplast Corp | $244.33 | 2020-2025 | |
| Pfizer INC. | $235.30 | 2019-2025 | |
| 180 Medical, INC. | $208.80 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $195.78 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Tolmar, INC. | $179.19 | 2023-2025 | Jatenzo, Eligard |
| Myriad Genetic Laboratories, INC. | $178.87 | 2022-2024 | Prolaris, Myrisk |
| C. R. Bard, INC. & Subsidiaries | $164.28 | 2019-2025 | Bard Urinary Drainage Bag, Aptra |
| Dentsply Sirona INC | $161.70 | 2020 | |
| Intuitive Surgical, INC. | $140.67 | 2023 | Da Vinci Surgical System |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $137.25 | 2021-2024 | Aquabeam Robotic System, Aquabeam System |
| Ferring Pharmaceuticals INC. | $100.56 | 2019-2025 | Adstiladrin |
| Caldera Medical, INC | $95.45 | 2022 | |
| Endo Pharmaceuticals INC. | $92.20 | 2019-2024 | Aveed, Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $84.17 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $80.21 | 2019-2022 | |
| Profound Medical Corp. | $75.60 | 2021-2025 | Tulsa-Pro |
| Urovant Sciences INC | $75.11 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $61.35 | 2019-2022 | |
| Hollister Incorporated | $58.09 | 2021-2023 | Vapro Pocket |
| Alnylam Pharmaceuticals INC. | $56.34 | 2023-2025 | Givlaari |
| Axonics, INC. | $55.40 | 2020-2024 | Axonics, Bulkamid |
| Olympus America INC. | $51.80 | 2023-2025 | Itind System |
| Allergan, INC. | $42.49 | 2020-2021 | |
| Antares Pharma, INC. | $41.08 | 2019-2022 | |
| Endo USA, INC. | $40.62 | 2024-2025 | Aveed, Xiaflex |
| Myovant Sciences INC. | $34.73 | 2021 | |
| Angiodynamics, INC. | $32.35 | 2022 | |
| Integra Lifesciences Corporation | $32.03 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Tempus Ai, INC | $31.59 | 2025 | Xt Cdx |
| Convatec INC. | $26.86 | 2025 | |
| Agiliti Surgical, INC. | $26.10 | 2023 | Sonablate |
| Amgen INC. | $20.27 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $20.08 | 2023 | Seglentis |
| Dentsply Ih INC. | $19.82 | 2019 | |
| Halozyme INC | $16.33 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.94 | 2023 | Lynparza |
| Rochester Medical Corporation | $14.78 | 2022 | |
| Medtronic USA, INC. | $13.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.